Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Study to Evaluate Long Term Treatment Effect of DiaPep277® in Patients Who Have Completed Studies 461* (Phase II) or 901** (Pase III)

NCT00644501 is registered in ClinicalTrials.gov with Andromeda Biotech Ltd. as lead sponsor.

NCT NCT00644501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00644501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Study to Evaluate Long Term Treatment Effect of DiaPep277® in Patients Who Have Completed Studies 461* (Phase II) or 901** (Pase III)
Lead sponsor
Andromeda Biotech Ltd.
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2008
Completion date
June 30, 2013
Enrollment
43 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes